iguratimod   Click here for help

GtoPdb Ligand ID: 9736

Synonyms: Careram® | Iremod | Kolbet® | T-614
Approved drug Immunopharmacology Ligand
iguratimod is an approved drug (China (2011), Japan (2012))
Compound class: Synthetic organic
Comment: Iguratimod is a methanesulfonanilide disease-modifying anti-rheumatic drug [1,5-6]. Evidence from a mouse colitis model shows an anti-inflammatory effect of iguratimod, partly via regulation of Th17/Treg cells [4], that suggest iguratimod as a novel therapeutic for the treatment of IBD.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 123.09
Molecular weight 374.06
XLogP 2.78
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=CNc1coc2c(c1=O)cc(c(c2)NS(=O)(=O)C)Oc1ccccc1
Isomeric SMILES O=CNc1coc2c(c1=O)cc(c(c2)NS(=O)(=O)C)Oc1ccccc1
InChI InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20)
InChI Key ANMATWQYLIFGOK-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Iguratimod is approved in China and Japan for the management of rheumatoid arthritis.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Iguratimod inhibits the production of immunoglobulins and a range of inflammatory cytokines, and exerts anabolic effects on bone metabolism by stimulating osteoblastic differentiation and inhibiting osteoclastogenesis [6]